The 2023-2028 World Outlook for Asthma Treatments - Image 1

Out of stock

This item is currently unavailable

The 2023-2028 World Outlook for Asthma Treatments

Subjects

Out of stock

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 270 days. Could come back at any time — we're watching for you.

Out of stock 270 days · last price £795 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 419 days · 419 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 419 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (419 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 419 days

Description

This study covers the world outlook for asthma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of asthma treatments as including all commonly understood services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AstraZeneca, Boehringer Ingelheim International, F. Hoffmann-La Roche, Genentech, GlaxoSmithKline, Innoviva, MAP Pharmaceuticals, Merck, Mylan NV, Novartis, Sanofi, Sunovion, Teva Pharmaceutical Industries, and Theravance. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09WCBLZLP
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 02 May 2022

The 2023-2028 World Outlook for Asthma Treatments

Gone for 270 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Asthma Treatments

The 2023-2028 Outlook for Asthma Treatments in the United States

The 2023-2028 Outlook for Asthma Treatments in China

The 2023-2028 Outlook for Asthma Treatments in India

The 2023-2028 Outlook for Asthma Treatments in Japan

The 2025-2030 World Outlook for Anti-Inflammatory Asthma Drugs

The 2023-2028 Outlook for Asthma Spacers in the United States

The 2023-2028 Outlook for Asthma Therapeutics in Japan

The 2023-2028 World Outlook for Anti-Inflammatory Asthma Drugs

The 2023-2028 Outlook for Asthma Spacers in India

The 2023-2028 Outlook for Asthma Treatments for US Zip Codes

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in China

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in Japan

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs for US Zip Codes

The 2023-2028 Outlook for Asthma Spacers for US Zip Codes

Asthma: Clinical Diagnosis and Therapeutics

Asthma - Diagnosis, Management and Comorbidities

The 2013-2018 Outlook for Bronchial Dilator and Anti-Asthmatic Pharmaceutical Preparations in India

How the home environment influences asthma: Residential Characteristics, Indoor Allergens and Adult Asthma

Types de personnalité et gravité de l'asthme: Relation entre les types et les traits de personnalité et la gravité de l'asthme chez les personnes âgées

Recent Advances in Asthma Research and Treatments

Severe Asthma in Children and Adolescents: Mechanisms and Management

Asthma (Practical Clinical Medicine)